WHO Mpox Clinical Data Platform
  • At a glance
  • Cases description
  • Skin lesions
  • Symptoms
  • HIV status

Total countries

11

Total cases

1667

Total facilities

63

Women

2.3%

Total PLWH

1008

Total deaths

19

Geospatial distribution
Cases reported
Mirror plots
Chronic conditions
Variable Sample size Prevalence pct Frequency
Cardiac 1104 0.4% 4 / 1104
Pulmonary 1130 0.5% 6 / 1130
HIV 1621 62.2% 1008 / 1621
TB 714 0.7% 5 / 714
Neurological 1129 0.7% 8 / 1129
Kidney disease 1131 0.3% 3 / 1131
Liver disease 1129 0.5% 6 / 1129
Malignant neoplasm 1127 0.7% 8 / 1127
STI 1532 18.1% 277 / 1532
Smoking 1081 10.3% 111 / 1081
Alcohol 658 6.7% 44 / 658
Hypertension 1132 3.0% 34 / 1132
On HIV ART 1008 84.7% 854 / 1008
Diabetes 968 0.9% 9 / 968

Source: WHO

Complications
Variable Sample size Prevalence pct Frequency
Shock 766 0.9% 7 / 766
Seizure 762 0.1% 1 / 762
Meningitis 763 0.5% 4 / 763
Anaemia 714 2.1% 15 / 714
Cardiac Arrhythmia 763 0.1% 1 / 763
Cardiac Arrest 763 0.5% 4 / 763
Pneumonia 760 1.2% 9 / 760
Cellulitis 1062 4.2% 45 / 1062
Ards 763 1.2% 9 / 763
Necrotizing Infection 1059 0.8% 9 / 1059
Abscess 1055 2.3% 24 / 1055
Bacteraemia 1071 0.6% 6 / 1071
Bleeding Disorder 763 0.7% 5 / 763
Acute Renal Injury 763 0.7% 5 / 763
Liver Dysfunction 714 0.7% 5 / 714
Urinary Retention 1057 0.7% 7 / 1057
Ocular Infection 1067 0.7% 8 / 1067
Sepsis 392 3.6% 14 / 392
Encephalitis 388 0.5% 2 / 388
Rectal Pain 380 7.1% 27 / 380
Proctitis 378 9.5% 36 / 378
Rectal Urgency 375 0.8% 3 / 375

Source: WHO

Body map
Prevalence of lesions
Variable Sample size Prevalence pct Frequency
Face 1481 31.4% 465/1481
Nares 1160 4.6% 53/1160
Mouth 1463 14.8% 216/1463
Chest 1463 35.3% 516/1463
Abdomen 1164 14.3% 166/1164
Back 1161 11.3% 131/1161
Perianal 1473 19.1% 281/1473
Genitals 1512 49.9% 754/1512
Palms 1154 10.8% 125/1154
Arms 1471 34.5% 508/1471
Thighs 1161 12.3% 143/1161
Legs 1463 36.6% 535/1463
Soles 1149 4.4% 51/1149
Forearms 1163 14.2% 165/1163
Rectal 1075 13.7% 147/1075

Source: WHO

Type of lesions
Variable Sample size Prevalence pct Frequency
Face 1481 31.4% 465/1481
Nares 1160 4.6% 53/1160
Mouth 1463 14.8% 216/1463
Chest 1463 35.3% 516/1463
Abdomen 1164 14.3% 166/1164
Back 1161 11.3% 131/1161
Perianal 1473 19.1% 281/1473
Genitals 1512 49.9% 754/1512
Palms 1154 10.8% 125/1154
Arms 1471 34.5% 508/1471
Thighs 1161 12.3% 143/1161
Legs 1463 36.6% 535/1463
Soles 1149 4.4% 51/1149
Forearms 1163 14.2% 165/1163
Rectal 1075 13.7% 147/1075

Source: WHO

Reported symptoms
Symptoms at admission
Variable Sample size Prevalence pct Frequency
Chest pain 745 5.5% 41 / 745
Decreased urine 747 0.1% 1 / 747
Diarrhoea 1450 1.9% 27 / 1450
Difficulty swallowing 749 3.2% 24 / 749
Dizziness 1130 0.5% 6 / 1130
Fatigue 1477 31.2% 461 / 1477
Headache 1471 32.7% 481 / 1471
Joint pain 1440 8.5% 123 / 1440
Lymphadenopathy 1472 45.2% 666 / 1472
Muscle aches 1476 33.1% 488 / 1476
Nausea 1139 7.4% 84 / 1139
Ocular symptoms 1441 4.1% 59 / 1441
Oral pain 746 6.8% 51 / 746
Proctitis 1449 8.4% 121 / 1449
Psychologic disturbance 1117 0.8% 9 / 1117
Rectal pain 1448 15.3% 221 / 1448
Sore throat 1472 18.8% 277 / 1472
Swallowing pain 1449 7.3% 106 / 1449
Urethritis 1066 6.2% 66 / 1066
Urination pain 1068 11.3% 121 / 1068
Vomiting 1061 2.8% 30 / 1061

Source: WHO

Symptoms at discharge
Variable Sample size Prevalence pct Frequency
Chest pain 334 0.3% 1 / 334
Decreased urine 332 0.3% 1 / 332
Diarrhoea 334 1.8% 6 / 334
Difficulty swallowing 334 0.9% 3 / 334
Dizziness 334 0.3% 1 / 334
Fatigue 333 8.1% 27 / 333
Headache 333 1.8% 6 / 333
Joint pain 332 1.2% 4 / 332
Lymphadenopathy 248 8.5% 21 / 248
Muscle aches 333 2.7% 9 / 333
Nausea 333 0.9% 3 / 333
Ocular symptoms 332 0.6% 2 / 332
Oral pain 331 1.2% 4 / 331
Proctitis 334 4.2% 14 / 334
Psychologic disturbance 328 0.9% 3 / 328
Rectal pain 331 3.6% 12 / 331
Sore throat 336 0.6% 2 / 336
Swallowing pain 333 1.2% 4 / 333
Urethritis 332 1.5% 5 / 332
Urination pain 334 2.7% 9 / 334
Vomiting 333 0.9% 3 / 333

Source: WHO

Population characteristics by HIV status
Variable

People with HIV, N = 1,446

Peoples without HIV, N = 1,088

Unknown HIV status, N = 129

Age, Median (IQR) 34 (27, 40) 30 (24, 36) 29 (-29, 34)
    Missing/Unknown 560 359 25
Sex at birth, n (%)


    Male 1,436 (99%) 1,021 (94%) 117 (91%)
    Female 9 (0.6%) 65 (6.0%) 12 (9.3%)
    Intersex 0 (0%) 1 (<0.1%) 0 (0%)
    Not specified 0 (0%) 0 (0%) 0 (0%)
    Missing/Unknown 1 1 0
Health care worker?, n (%)


    Yes 74 (5.7%) 54 (6.2%) 3 (3.2%)
    No 1,013 (78%) 655 (75%) 85 (89%)
    Unknown 217 (17%) 165 (19%) 7 (7.4%)
    Missing/Unknown 142 214 34
HIV (Human Immunodeficiency Virus), n (%)


    Yes (on antiretroviral therapy/ART) 1,111 (77%) 0 (0%) 0 (0%)
    Yes (not on antiretroviral therapy/ART) 104 (7.2%) 0 (0%) 0 (0%)
    Yes (unknown if on antiretroviral therapy/ART) 231 (16%) 0 (0%) 0 (0%)
    No 0 (0%) 1,088 (100%) 0 (0%)
    Unknown 0 (0%) 0 (0%) 129 (100%)
Lesions by HIV status
Complications by HIV status


This dashboard displays statistics for:

Total cases: 1667
Total reporting countries 11
As of: 2024-07-26




Disclaimer

This is a brief overview of the data reported to the WHO Clinical data platform for mpox.